FDA product code KQE: Assay, Erythrocytic Glucose-6-Phosphate Dehydrogenase

KQE is the FDA product code for assay, erythrocytic glucose-6-phosphate dehydrogenase. It is a Class II device, regulated under 21 CFR 864.7360 and reviewed by the Hematology panel. FDA has cleared 1 510(k) submission under KQE. The average 510(k) review took 39 days (median 39).

Classification

FieldValue
Device nameAssay, Erythrocytic Glucose-6-Phosphate Dehydrogenase
Device classClass II
Regulation21 CFR 864.7360
Review panelHE — Hematology
Medical specialtyHematology
Premarket route510(k)
Third-party 510(k) review eligibleYes

Compare with all 510(k) review times · Search every KQE clearance

Top KQE applicants

ApplicantClearancesLatest
Alladin Diagnostic, Inc.11983-02-07

Most recent KQE clearances

510(k)ApplicantDeviceDecision dateReview days
K823900Alladin Diagnostic, Inc.GLUCOSE-6-PHOSPHATE DEHYDROGENASE1983-02-0739

Recalls for KQE devices

openFDA lists no recalls for product code KQE.

Frequently asked questions

What is FDA product code KQE?

KQE is the FDA product code for assay, erythrocytic glucose-6-phosphate dehydrogenase. It is a Class II device, regulated under 21 CFR 864.7360 and reviewed by the Hematology panel.

What device class is KQE?

Class II, regulation 21 CFR 864.7360. Typical premarket route: 510(k).

How long does a 510(k) take for product code KQE?

Across 1 cleared submissions the average was 39 days from receipt to decision (median 39).

Which companies have the most KQE clearances?

Alladin Diagnostic, Inc. (1).

Next steps

Source: openFDA device classification, 510(k), PMA, De Novo and recall data (public domain). Review days run from FDA receipt to decision. Not regulatory advice.

All Hematology product codes · FDA product code lookup · 510(k) database search · 510(k) review times